Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sopp JM"'
Autor:
Hussain, K, Hargreaves, CE, Rowley, TF, Sopp, JM, Latham, KV, Bhatta, P, Sherington, J, Cutler, RM, Humphreys, DP, Glennie, MJ, Strefford, JC, Cragg, MS
Publikováno v:
Frontiers in Immunology
Monoclonal antibody (mAb) immunotherapy has transformed the treatment of allergy, autoimmunity, and cancer. The interaction of mAb with Fc gamma receptors (FcγR) is often critical for efficacy. The genes encoding the low-affinity FcγR have single n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1b7e94b222d525446333af6493afa377
http://europepmc.org/articles/PMC6417454
http://europepmc.org/articles/PMC6417454
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sopp JM; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Peters SJ; UCB Pharma, Slough, UK., Rowley TF; UCB Pharma, Slough, UK., Oldham RJ; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., James S; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Mockridge I; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., French RR; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Turner A; UCB Pharma, Slough, UK., Beers SA; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Humphreys DP; UCB Pharma, Slough, UK., Cragg MS; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK. msc@soton.ac.uk.
Publikováno v:
Communications biology [Commun Biol] 2021 Sep 02; Vol. 4 (1), pp. 1031. Date of Electronic Publication: 2021 Sep 02.
Autor:
Rowley TF; UCB Pharma, 216 Bath Road, Slough, SL1 3WE, UK. tania.rowley@ucb.com., Peters SJ; UCB Pharma, 216 Bath Road, Slough, SL1 3WE, UK., Aylott M; Statistical Consultant, St Albans, UK., Griffin R; UCB Pharma, 216 Bath Road, Slough, SL1 3WE, UK., Davies NL; UCB Pharma, 216 Bath Road, Slough, SL1 3WE, UK., Healy LJ; Aurelia Bioscience, Nottingham, UK., Cutler RM; UCB Pharma, 216 Bath Road, Slough, SL1 3WE, UK., Eddleston A; UCB Pharma, 216 Bath Road, Slough, SL1 3WE, UK., Pither TL; Institute of Cellular Medicine, Newcastle University Medical School, Newcastle upon Tyne, UK., Sopp JM; Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, UK., Zaccheo O; UCB Pharma, 216 Bath Road, Slough, SL1 3WE, UK., Fossati G; Eurofins Pharma Bioanalysis Services UK Ltd, Abingdon, UK., Cain K; Vertex, Abingdon, UK., Ventom AM; UCB Pharma, 216 Bath Road, Slough, SL1 3WE, UK., Hailu H; UCB Pharma, 216 Bath Road, Slough, SL1 3WE, UK., Ward EJ; Biochemical Pharmacology William Harvey Research Institute, Queen Mary University of London, London, UK., Sherington J; UCB Pharma, 216 Bath Road, Slough, SL1 3WE, UK., Brennan FR; UCB Pharma, 216 Bath Road, Slough, SL1 3WE, UK., Fallah-Arani F; UCB Pharma, 216 Bath Road, Slough, SL1 3WE, UK., Humphreys DP; UCB Pharma, 216 Bath Road, Slough, SL1 3WE, UK.
Publikováno v:
Communications biology [Commun Biol] 2018 Sep 14; Vol. 1, pp. 146. Date of Electronic Publication: 2018 Sep 14 (Print Publication: 2018).